Evidence map›Paper›PMID 35886450›Full record

ArticleInternational journal of environmental research and public health2022

Occupational Exposure Assessment to Antineoplastic Drugs in Nine Italian Hospital Centers over a 5-Year Survey Program.

Cristina Sottani, Elena Grignani, Marco Cornacchia, Sara Negri, Francesco Saverio Robustelli Della Cuna, Danilo Cottica, Dario Bruzzese, Paolo Severi, Daniele Strocchi, Giovanni Verna and 2 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.International archives of occupational and environmental health · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cristina SottaniEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.ORCID 0000-0001-9103-7367
Elena GrignaniEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.
Marco CornacchiaDeparment of Drug Science, University of Pavia, 27100 Pavia, Italy.
Sara NegriEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.
Francesco Saverio Robustelli Della CunaEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.
Danilo CotticaEnvironmental Research Center, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.
Dario BruzzeseDepartment of Public Health, Section of Medical Statistics, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0001-9911-4646
Paolo SeveriPrevention and Protention Service, Azienda Unità, Sanitaria Locale della Romagna Ospedali degli ambiti territoriali di Ravenna e Rimini dell'AUSL della Romagna, 47521 Cesena, Italy.
Daniele StrocchiPrevention and Protention Service, Azienda Unità, Sanitaria Locale della Romagna Ospedali degli ambiti territoriali di Ravenna e Rimini dell'AUSL della Romagna, 47521 Cesena, Italy.
Giovanni VernaPrevention and Protention Service, Azienda Unità, Sanitaria Locale della Romagna Ospedali degli ambiti territoriali di Ravenna e Rimini dell'AUSL della Romagna, 47521 Cesena, Italy.
Veruscka LesoDepartment of Public Health, Section of Occupational Medicine, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-3039-2856
Ivo IavicoliDepartment of Public Health, Section of Occupational Medicine, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0003-0444-3792

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, surface contamination where antineoplastic drugs (ADs) are present was investigated, as occupational exposure risk is still an open debate. Despite recommendations and safety standard procedures being in place in health care settings, quantifiable levels of ADs are being reported in the recent literature. Thus, a survey monitoring program was conducted over five years (2016-2021) in nine Italian hospitals. The repeated surveys produced 8288 data points that have been grouped according to the main hospital settings, such as pharmacy areas and patient care units. Based on the most often prepared ADs, the investigated drugs were cyclophosphamide (CP), gemcitabine (GEM), 5-fluorouracil (5-FU), and platinum compounds (Pt). Patient care units had a frequency of positive wipe samples (59%) higher than pharmacies (44%). Conversely, pharmacies had a frequency of positive pad samples higher (24%) than patient care units (10%). Moreover, by statistical analysis, pad samples had a significantly higher risk of contamination in pharmacy areas than in patient care units. In this study, the 75th and the 90th percentiles of the contamination levels were obtained. The 90th percentile was chosen to describe a suitable benchmark that compares results obtained by the present research with those previously reported in the literature. Based upon surface contamination loads, our data showed that 5-FU had the highest concentration values, but the lowest frequency of positive samples. In pharmacy areas, the 90th percentile of 5-FU data distribution was less than 0.346 ng/cm

Indexed as

Antineoplastic AgentsOccupational ExposureEnvironmental MonitoringEquipment ContaminationFluorouracilHospitalsHumansAntineoplastic AgentsFluorouracilchemotherapeutic drugsfrequency of positive samplespercentiles of data distributiontemporal trendsthreshold exposure limits

Identifiers

PMID35886450
PMCPMC9321125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.